36 completed, 10 recruiting, 5 not yet recruiting, 5 unknown. 66 Phase 2, 11 Phase 1, 10 Phase 3.
Follow Placebo Control: new trials by email Literature Review of Placebo Control trials Research Report on Placebo Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis TG-C, Placebo Control - Degenerative Osteoarthritis | Phase 2 | Not yet recruiting | Kolon TissueGene, Inc. | 255 | 2027-10-01 | 2026-08-20 |
| Study of CU06-1004 in Patients With Daibetic Macular Edema CU06-1004, Placebo Control - DME, Diabetic Macular Edema | Phase 2 | Not yet recruiting | Curacle Co., Ltd. | 156 | 2026-12-01 | 2026-10-23 |
| A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521 Infusions in the Early Recovery Treatment From Acute Ischemic Stroke NTS-521, Placebo Control - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | NeuroTrauma Sciences, LLC | 140 | 2026-10-31 | 2026-08-03 |
| NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease Droxidopa Oral Product, Placebo Control - Menkes Disease | Phase 1 / Phase 2 | Recruiting | Stephen G. Kaler | 6 | 2026-08-10 | 2026-10-05 |
| Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. Dried chicory roots, Placebo - Melanoma (Skin) Stage IV, Melanoma (Skin Cancer) | Phase 2 | Recruiting | Radboud University Medical Center | 70 | 2026-07-31 | 2026-07-27 |
| Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage Placebo control, Recombinant G-CSF - Recurrent Pregnancy Loss, Recurrent Miscarriages | Phase 2 | Recruiting | Fakih IVF Fertility Center | 150 | 2026-07-10 | 2026-07-24 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery HSK55718 dose level1, HSK55718 dose level2, HSK55718 dose level 3 - Pain After Surgery | Phase 2 | Recruiting | Haisco Pharmaceutical Group Co., Ltd. | 200 | 2026-05-22 | 2026-05-28 |
| To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease Dronabinol Oral Solution, Placebo Control - Agitation in Dementia | Phase 2 / Phase 3 | Not yet recruiting | Benuvia Therapeutics Inc. | 140 | 2026-05-01 | 2026-02-25 |
| A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV Resmetirom, Placebo Control - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, HIV (Human Immunodeficiency Virus) | Phase 2 | Recruiting | Naga P. Chalasani | 120 | 2026-04-23 | 2026-07-30 |
| PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia PVX4 Combination Product, Placebo Control - Cervical Intraepithelial Neoplasia Grade 2/3, Human Papilloma Virus Infection Type 16 | Phase 2 | Recruiting | PapiVax Biotech, Inc. | 138 | 2026-04-01 | 2026-05-06 |
| Thymosin-α1 for Recurrent Implantation Failure Thymosin Alpha1, Placebo Control - Recurrent Implantation Faliure | Phase 2 / Phase 3 | Recruiting | Fakih IVF Fertility Center | 136 | 2026-02-11 | 2026-10-15 |
| Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study Probiotic, Placebo Control - URTI | Phase 2 | Enrolling by invitation | Min-Tze LIONG | 120 | 2026-02-01 | 2026-04-02 |
| Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity RN3161, Placebo Control, Tirzepatide - Obesity &Amp; Overweight | Phase 1 / Phase 2 | Recruiting | Ikaria Bioscience Pty Ltd | 104 | 2025-11-04 | 2025-11-24 |
| hUC-MSC-Exo Therapy for Autoimmune Encephalitis Human umbilical cord mesenchymal stem cell derived exosomes, Placebo Control - Autoimmune Encephalitis | Phase 1 / Phase 2 | Not yet recruiting | Xuanwu Hospital, Beijing | 38 | 2025-11-01 | 2025-08-20 |
| Phase 2b Study of EVO756 in Adults With Atopic Dermatitis EVO756, Placebo control - Atopic Dermatitis | Phase 2 | Completed | Evommune, Inc. | 121 | 2025-08-26 | 2026-10-05 |
| Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) EVO756, Placebo control - Chronic Spontaneous Urticaria | Phase 2 | Completed | Evommune, Inc. | 182 | 2025-03-20 | 2026-07-01 |
| Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm Endothelin Receptor Antagonist, Placebo control - Coronary Spasm | Phase 2 / Phase 3 | Enrolling by invitation | Radboud University Medical Center | 100 | 2024-11-11 | 2024-11-18 |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy Rivaroxaban 10 MG, Placebo control - Venous Thromboembolism, Urologic Cancer | Phase 2 / Phase 3 | Recruiting | Ottawa Hospital Research Institute | 120 | 2024-11-04 | 2025-07-10 |
| Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents Recombinant COVID-19 vaccine (Sf9 cells), Placebo control - COVID-19 | Phase 1 / Phase 2 | Withdrawn | WestVac Biopharma Co., Ltd. | 2024-07-01 | 2025-03-28 | |
| SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes Empagliflozin, Placebo Control - Cystic Fibrosis-related Diabetes, Cystic Fibrosis | Phase 2 / Phase 3 | Active not recruiting | University of Minnesota | 8 | 2024-01-08 | 2026-09-21 |
Showing 20 of 66. Sign in to see all of them.
Hypersensitivity (4) · Acquired Immunodeficiency Syndrome (2) · Alzheimer Disease (2) · Arthritis, Rheumatoid (2) · COVID-19 (2) · Dermatitis, Atopic (2) · Diabetes Mellitus (2) · Eczema (2) · Epilepsy (2) · Fatty Liver (2) · Osteoarthritis, Knee (2) · Uterine Cervical Dysplasia (2) · Aberrant Motor Behavior in Dementia (1) · Abortion, Habitual (1) · Abortion, Spontaneous (1)
Jazz Pharmaceuticals (4) · Artu Biologicals (2) · Evommune, Inc. (2) · Fakih IVF Fertility Center (2) · GW Research Ltd (2) · Radboud University Medical Center (2) · Advaxis, Inc. (1) · Baylor University (1) · Beijing Hospital (1) · Beijing VDJBio Co., LTD. (1) · Benuvia Therapeutics Inc. (1) · Bioventus LLC (1) · Can-Fite BioPharma (1) · Charsire Biotechnology Corp. (1) · Children's National Research Institute (1)
United States (24) · China (7) · Canada (6) · United Kingdom (6) · Germany (4) · Netherlands (4) · Australia (3) · Bulgaria (3) · Czechia (3) · Hungary (3) · India (3) · Lithuania (3) · Malaysia (3) · Poland (3) · Denmark (2)
Alan S. Lader, Ph.D. (2) · Abdullah Baqui, MBBS (1) · Anbin Huang, MD. (1) · Ashok Seth, FRCP, FACC (1) · Bijoy A Menon, MD (1) · Christine L Lau, MD, MBA (1) · Daniel Roth, MD (1) · David A Dill (1) · Dongbao Zhao, MD. (1) · Dyonne van Duren, MD, PhD (1) · Emily Lin (1) · Fen Li, MD. (1) · Fengcai Zhu (1) · Folkert R Roossien (1)
PMID 18598362, PMID 20576835, PMID 21127322, PMID 23587190, PMID 23998516, PMID 24937546, PMID 27506771, PMID 27648659, PMID 29538683, PMID 30592553, PMID 33998885, PMID 39077939, PMID 39234416, PMID 39704612, PMID 40274007, PMID 40781582
2014 (2), 2009 (1), P50NS044227 (1), R01DA019992 (1)